British Columbian Cannabis Genetics Touch Down in the EU

Tilray, a GMP-certified global leader in medical cannabis research and production, today announced that the company has successfully exported live medical cannabis genetics from its flagship British Columbia, Canada facility to its European Union Campus in Cantanhede, Portugal. The announcement is the first time a company has legally exported live cannabis genetics from North America … Continued

Watching the Canadian Cannabis Industry Evolve

Lamps, fertilisers, harvesting tools and security devices, inventory software, storage containers and testing equipment – such products are already used by the black market in every country where cannabis is classified as an illegal drug. And yet last weekend here in Niagara, Ontario, for a special conference and expo were the black market’s mainstream counterparts and … Continued

Tilray to Invest Massively in European Facility

Tilray, a global pioneer in medical cannabis research, recently announced plans to invest up to €20 million (£18 million) in a European Union Campus (EU Campus) after receiving licences from the Government of Portugal to import cannabis genetics and to cultivate cannabis for medical purposes. The EU Campus will include indoor, outdoor, and greenhouse cultivation … Continued

Pot With Patents Could Plant the Seeds of Future Lawsuits

This article was originally published on The Conversation. It’s hard to make sense of cannabis regulation. The Drug Enforcement Agency (DEA) continues to categorize marijuana as a Schedule I drug. That means the government believes it has “no currently accepted medical use and a high potential for abuse,” putting it in the same league as LSD and … Continued